arrow
袁

袁庶强 (Shuqiang Yuan)

Sun Yat-sen University Cancer Center邮箱:yuanshq@sysucc.org.cn
H指数:24
被引数:1,886

个人简介

"2000.09-2005.07,中山大学中山医学院,临床医学学士 2005.09-2008.07,中山大学肿瘤防治中心,肿瘤学硕士 2009.04-2011.05,美国M. D. Anderson肿瘤中心,联合培养博士 2008.09-2011.07,中山大学,附属第六医院,外科学博士 2011.07-2013.12,中山大学肿瘤防治中心胃外科,住院医师 2014.01-2017.12,中山大学肿瘤防治中心胃外科,主治医师 2018.01-2023.12,中山大学肿瘤防治中心胃外科,副主任医师 2024.01-至今,中山大学肿瘤防治中心胃外科,主任医师"

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Developing Personalized Postoperative Follow-Up Strategies for Patients With Locally Advanced Gastric Cancer Receiving Neoadjuvant Therapy Based on Dynamic Programming: A Multicenter Retrospective Cohort Study in China

基于动态规划开发局部晚期胃癌新辅助治疗患者的个性化术后随访策略:一项中国多中心回顾性队列研究

2026-09-010
PRE
Neoadjuvant toripalimab plus CapeOX in locally advanced Epstein-Barr virus-associated gastric or gastroesophageal junction adenocarcinoma: a phase Ⅱ trial

新辅助特瑞普利单抗联合CapeOX方案治疗局部晚期EB病毒相关胃或胃食管结合部腺癌:一项Ⅱ期临床试验

2026-04-230
OAAI
The INSPECTOR study: enhanced feasibility for clinical translation of a multi-cancer early detection method based on enzyme-assisted high signal-to-noise ratio sequencing of methylated circulating tumor DNA

INSPECTOR研究:基于酶辅助高信噪比测序甲基化循环肿瘤DNA的多癌种早期检测方法的临床转化可行性提升

2025-10-300
OAAI
Efficacy and safety of neoadjuvant toripalimab plus chemotherapy in localized deficient mismatch repair/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma (NICE): a multicentre, single-arm, exploratory phase 2 study

尼妥珠单抗联合化疗在局部错配修复缺陷/微卫星高度不稳定胃或食管胃结合部腺癌中的有效性和安全性(NICE):一项多中心、单臂、探索性Ⅱ期研究

2025-08-120
PREAI
Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial

围术期替雷利珠单抗联合化疗治疗局部晚期胃食管结合部腺癌(NEOSUMMIT-03):一项前瞻性、非随机、开放标签、Ⅱ期临床试验

2025-02-050
OA
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial (vol 30, pg 552, 2024)

围手术期toripalimab和化疗治疗局部晚期胃癌或胃食管交界处癌: 一项随机2期试验 (第30卷,552页,2024)

2024-01-081
OA
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial

围手术期toripalimab和化疗治疗局部晚期胃癌或胃食管交界处癌: 一项随机2期试验

2024-01-0231
PRE
Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II-III gastric cancer

辅助化疗后残留的循环肿瘤DNA能够有效预测II–III期胃癌的复发。

2023-10-144
OAAI